Browse the full record of transactions filed by Fenimore Christopher R., Chief Financial Officer. Insider active across 1 companies, notably Regeneron Pharmaceuticals, INC.. Aggregated, 10 filings have been logged. The latest transaction was filed on 8 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Christopher R. Fenimore is the Chief Financial Officer at Regeneron Pharmaceuticals, Inc. As SVP Controller, he oversees the accounting and financial operations of the company. His expertise is essential for ensuring compliance and financial transparency within Regeneron Pharmaceuticals, Inc.